• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

溃疡性结肠炎相关的共生病原体在易感性宿主中增强结肠炎。

Ulcerative Colitis-associated pathobionts potentiate colitis in susceptible hosts.

机构信息

Department of Pediatrics, BC Children's Hospital, University of British Columbia , Vancouver, BC, Canada.

Department of Bacteria, Parasites and Fungi, Statens Serum Institute , Copenhagen, Denmark.

出版信息

Gut Microbes. 2020 Nov 9;12(1):1847976. doi: 10.1080/19490976.2020.1847976. Epub 2020 Dec 1.

DOI:10.1080/19490976.2020.1847976
PMID:33258388
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7781664/
Abstract

Ulcerative colitis (UC) is a chronic inflammatory condition linked to intestinal microbial dysbiosis, including the expansion of strains related to extra-intestinal pathogenic . These "pathobionts" exhibit pathogenic properties, but their potential to promote UC is unclear due to the lack of relevant animal models. Here, we established a mouse model using a representative UC pathobiont strain (p19A), and mice lacking single immunoglobulin and toll-interleukin 1 receptor domain (SIGIRR), a deficiency increasing susceptibility to gut infections. Strain p19A was found to adhere to the cecal mucosa of -/- mice, causing modest inflammation. Moreover, it dramatically worsened dextran sodium sulfate-induced colitis. This potentiation was attenuated using a p19A strain lacking α-hemolysin genes, or when we targeted pathobiont adherence using a p19A strain lacking the adhesin FimH, or following treatment with FimH antagonists. Thus, UC pathobionts adhere to the intestinal mucosa, and worsen the course of colitis in susceptible hosts.

摘要

溃疡性结肠炎(UC)是一种与肠道微生物失调相关的慢性炎症性疾病,包括与肠道外致病性相关菌株的扩张。这些“条件致病菌”具有致病性,但由于缺乏相关的动物模型,其促进 UC 的潜力尚不清楚。在这里,我们使用代表性的 UC 条件致病菌(p19A)株建立了一种小鼠模型,以及缺乏单一免疫球蛋白和 Toll-白细胞介素 1 受体域(SIGIRR)的小鼠,这种缺陷会增加对肠道感染的易感性。发现 p19A 株黏附于 -/- 小鼠的盲肠黏膜,引起适度的炎症。此外,它还显著加重了葡聚糖硫酸钠诱导的结肠炎。使用缺乏α-溶血素基因的 p19A 株、使用缺乏黏附素 FimH 的 p19A 株靶向条件致病菌黏附、或在使用 FimH 拮抗剂治疗后,这种增强作用会减弱。因此,UC 条件致病菌黏附在肠道黏膜上,并在易感宿主中加重结肠炎的病程。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ad5/7781664/2c0f9d6b5eac/KGMI_A_1847976_F0005_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ad5/7781664/8e758ea60c0e/KGMI_A_1847976_F0001_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ad5/7781664/ec8856ab0891/KGMI_A_1847976_F0002_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ad5/7781664/405d7560da5e/KGMI_A_1847976_F0003_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ad5/7781664/42dcba368946/KGMI_A_1847976_F0004_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ad5/7781664/2c0f9d6b5eac/KGMI_A_1847976_F0005_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ad5/7781664/8e758ea60c0e/KGMI_A_1847976_F0001_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ad5/7781664/ec8856ab0891/KGMI_A_1847976_F0002_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ad5/7781664/405d7560da5e/KGMI_A_1847976_F0003_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ad5/7781664/42dcba368946/KGMI_A_1847976_F0004_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ad5/7781664/2c0f9d6b5eac/KGMI_A_1847976_F0005_OC.jpg

相似文献

1
Ulcerative Colitis-associated pathobionts potentiate colitis in susceptible hosts.溃疡性结肠炎相关的共生病原体在易感性宿主中增强结肠炎。
Gut Microbes. 2020 Nov 9;12(1):1847976. doi: 10.1080/19490976.2020.1847976. Epub 2020 Dec 1.
2
Microevolution in fimH gene of mucosa-associated Escherichia coli strains isolated from pediatric patients with inflammatory bowel disease.黏膜相关大肠杆菌菌株 fimH 基因的微进化,这些菌株是从患有炎症性肠病的儿科患者中分离出来的。
Infect Immun. 2012 Apr;80(4):1408-17. doi: 10.1128/IAI.06181-11. Epub 2012 Jan 30.
3
Effect of α-Hemolysin Producing in Two Different Mouse Strains in a DSS Model of Inflammatory Bowel Disease.α-溶血素在两种不同小鼠品系的炎症性肠病DSS模型中的产生效应。
Microorganisms. 2020 Dec 11;8(12):1971. doi: 10.3390/microorganisms8121971.
4
The prevalence of mucosa-associated diffusely adherent Escherichia coli in children with inflammatory bowel disease.黏附性弥漫型大肠埃希菌在炎症性肠病患儿中的流行情况。
Adv Clin Exp Med. 2019 Jul;28(7):899-905. doi: 10.17219/acem/94149.
5
Immune Stimulation Using a Gut Microbe-Based Immunotherapy Reduces Disease Pathology and Improves Barrier Function in Ulcerative Colitis.基于肠道微生物的免疫疗法刺激免疫可减轻溃疡性结肠炎的疾病病理并改善其屏障功能。
Front Immunol. 2018 Sep 27;9:2211. doi: 10.3389/fimmu.2018.02211. eCollection 2018.
6
Propionate catabolism by CD-associated adherent-invasive counteracts its anti-inflammatory effect.CD 相关黏附侵袭性对抗其抗炎作用的丙酸分解代谢。
Gut Microbes. 2021 Jan-Dec;13(1):1-18. doi: 10.1080/19490976.2020.1839318.
7
Characterization of mucosa-associated Escherichia coli strains isolated from Crohn's disease patients in Brazil.巴西克罗恩病患者分离的黏附性大肠埃希菌菌株的特性研究。
BMC Microbiol. 2020 Jun 23;20(1):178. doi: 10.1186/s12866-020-01856-x.
8
AIEC pathobiont instigates chronic colitis in susceptible hosts by altering microbiota composition.AIEC 共生菌通过改变微生物群落组成引发易感宿主的慢性结肠炎。
Gut. 2014 Jul;63(7):1069-80. doi: 10.1136/gutjnl-2013-304909. Epub 2013 Jul 29.
9
Colonic mucosa-associated diffusely adherent afaC+ Escherichia coli expressing lpfA and pks are increased in inflammatory bowel disease and colon cancer.黏附侵袭性大肠杆菌在炎症性肠病和结肠癌中表达 lpfA 和 pks,其与结肠黏膜相关且呈弥漫性黏附。
Gut. 2014 May;63(5):761-70. doi: 10.1136/gutjnl-2013-304739. Epub 2013 Jul 11.
10
Gut-derived Enterococcus faecium from ulcerative colitis patients promotes colitis in a genetically susceptible mouse host.溃疡性结肠炎患者肠道来源的粪肠球菌在遗传易感的小鼠宿主中促进结肠炎。
Genome Biol. 2019 Nov 25;20(1):252. doi: 10.1186/s13059-019-1879-9.

引用本文的文献

1
Fucoidan as a therapeutic agent for ulcerative colitis: mechanisms of action and modulation of the gut microbiota.岩藻依聚糖作为溃疡性结肠炎的治疗剂:作用机制及对肠道微生物群的调节
Front Cell Infect Microbiol. 2025 Jul 10;15:1626614. doi: 10.3389/fcimb.2025.1626614. eCollection 2025.
2
SIGIRR: An Orphan Receptor Mediating Anti-inflammatory Actions.信号抑制因子(SIGIRR):一种介导抗炎作用的孤儿受体
Expert Rev Mol Med. 2025 Jun 30;27:e24. doi: 10.1017/erm.2025.10009.
3
Exploring the Clinical Implication of S100A9 in Ulcerative Colitis and Its Progression to Cancer: A Journey from Inflammation to Cancer.

本文引用的文献

1
Pathobionts Associated with Inflammatory Bowel Disease.与炎症性肠病相关的病原菌。
Clin Microbiol Rev. 2019 Jan 30;32(2). doi: 10.1128/CMR.00060-18. Print 2019 Mar 20.
2
The Muc2 mucin coats murine Paneth cell granules and facilitates their content release and dispersion.黏蛋白 Muc2 覆盖了小鼠潘氏细胞颗粒,并促进其内容物的释放和分散。
Am J Physiol Gastrointest Liver Physiol. 2018 Aug 1;315(2):G195-G205. doi: 10.1152/ajpgi.00264.2017. Epub 2018 Apr 26.
3
Structure-based discovery of glycomimetic FmlH ligands as inhibitors of bacterial adhesion during urinary tract infection.
探索S100A9在溃疡性结肠炎及其癌变过程中的临床意义:从炎症到癌症的历程
Int J Mol Sci. 2025 Jun 13;26(12):5693. doi: 10.3390/ijms26125693.
4
Colonic Submucosa Targeted Delivery of Probiotic and Rhein for Ulcerative Colitis Treatment.用于溃疡性结肠炎治疗的益生菌和大黄素的结肠黏膜下层靶向递送
Adv Sci (Weinh). 2025 Aug;12(30):e2409711. doi: 10.1002/advs.202409711. Epub 2025 May 9.
5
exacerbates ulcerative colitis by inhibiting mucin production.通过抑制粘蛋白生成而加重溃疡性结肠炎。
Front Microbiol. 2025 Mar 25;16:1556953. doi: 10.3389/fmicb.2025.1556953. eCollection 2025.
6
Lineage-specific microbial protein prediction enables large-scale exploration of protein ecology within the human gut.谱系特异性微生物蛋白预测能够大规模探索人类肠道内的蛋白质生态学。
Nat Commun. 2025 Apr 3;16(1):3204. doi: 10.1038/s41467-025-58442-w.
7
Fibroblast Growth Factor 20 Attenuates Colitis by Restoring Impaired Intestinal Epithelial Barrier Integrity and Modulating Macrophage Polarization via S100A9 in an NF-κB-Dependent Manner.成纤维细胞生长因子20通过恢复受损的肠道上皮屏障完整性并以NF-κB依赖的方式经由S100A9调节巨噬细胞极化来减轻结肠炎。
Cell Mol Gastroenterol Hepatol. 2025;19(6):101486. doi: 10.1016/j.jcmgh.2025.101486. Epub 2025 Feb 28.
8
Interplay of m6A RNA methylation and gut microbiota in modulating gut injury.m6A RNA甲基化与肠道微生物群在调节肠道损伤中的相互作用。
Gut Microbes. 2025 Dec;17(1):2467213. doi: 10.1080/19490976.2025.2467213. Epub 2025 Feb 17.
9
Safety comparison of single-donor and pooled fecal microbiota transfer product preparation in ulcerative colitis: systematic review and meta-analysis.单供体与混合粪菌移植产品制备在溃疡性结肠炎中的安全性比较:系统评价和荟萃分析。
BMC Gastroenterol. 2024 Nov 11;24(1):402. doi: 10.1186/s12876-024-03487-2.
10
Effects of Pine Pollen Polysaccharides and Sulfated Polysaccharides on Ulcerative Colitis in Mice by Regulating Th17/Treg.松花粉多糖和硫酸化多糖通过调节Th17/Treg对小鼠溃疡性结肠炎的影响
Foods. 2024 Oct 7;13(19):3183. doi: 10.3390/foods13193183.
基于结构的聚糖模拟 FmlH 配体的发现作为尿路感染期间细菌黏附的抑制剂。
Proc Natl Acad Sci U S A. 2018 Mar 20;115(12):E2819-E2828. doi: 10.1073/pnas.1720140115. Epub 2018 Mar 5.
4
Context-Dependent Requirements for FimH and Other Canonical Virulence Factors in Gut Colonization by Extraintestinal Pathogenic Escherichia coli.肠道外致病性大肠杆菌在肠道定植中对 FimH 和其他经典毒力因子的上下文相关需求。
Infect Immun. 2018 Feb 20;86(3). doi: 10.1128/IAI.00746-17. Print 2018 Mar.
5
Adherent-invasive in inflammatory bowel disease.黏附侵袭型;炎症性肠病
Gut. 2018 Mar;67(3):574-587. doi: 10.1136/gutjnl-2017-314903. Epub 2017 Nov 15.
6
Role for FimH in Extraintestinal Pathogenic Escherichia coli Invasion and Translocation through the Intestinal Epithelium.菌毛黏附素FimH在肠道外致病性大肠杆菌侵袭及穿越肠上皮细胞中的作用
Infect Immun. 2017 Oct 18;85(11). doi: 10.1128/IAI.00581-17. Print 2017 Nov.
7
The potential of FimH as a novel therapeutic target for the treatment of Crohn's disease.FimH 作为一种新型治疗靶点在治疗克罗恩病中的潜力。
Expert Opin Ther Targets. 2017 Sep;21(9):837-847. doi: 10.1080/14728222.2017.1363184. Epub 2017 Aug 11.
8
Selective depletion of uropathogenic E. coli from the gut by a FimH antagonist.通过一种FimH拮抗剂选择性清除肠道中的尿路致病性大肠杆菌。
Nature. 2017 Jun 22;546(7659):528-532. doi: 10.1038/nature22972. Epub 2017 Jun 14.
9
Extraintestinal pathogenic Escherichia coli are associated with intestinal inflammation in patients with ulcerative colitis.肠外致病性大肠杆菌与溃疡性结肠炎患者的肠道炎症有关。
Sci Rep. 2016 Sep 30;6:31152. doi: 10.1038/srep31152.
10
The Antiadhesive Strategy in Crohn's Disease: Orally Active Mannosides to Decolonize Pathogenic Escherichia coli from the Gut.克罗恩病的抗黏附策略:口服活性甘露糖苷使肠道致病性大肠杆菌去定植
Chembiochem. 2016 May 17;17(10):936-52. doi: 10.1002/cbic.201600018. Epub 2016 Apr 8.